COMMUNIQUÉS West-GlobeNewswire

-
Press Release Biocartis NV: Biocartis Welcomes Ben Svarczkopf as Senior Vice President of Global Marketing
17/06/2025 -
Lisata Therapeutics and GATC Health Expand Relationship to Advance AI-Driven Drug Discovery and Development
17/06/2025 -
Elicio Therapeutics to Host Virtual KOL Event on June 25, 2025 to Discuss AMP-Powered ELI-002 for the Treatment of KRAS mutation-driven Pancreatic Cancer
17/06/2025 -
ORYZON to Attend the 2025 Phelan-McDermid Syndrome (PMS) Congress in Barcelona on June 26-29
17/06/2025 -
NeurAxis Announces New Medical Policy Coverage with Two Health Insurers, Adding 700,000 Covered Lives
17/06/2025 -
Marker Therapeutics and Cellipont Bioservices Announce Collaboration to Advance cGMP Manufacturing of MT-601, a Multi-Antigen Recognizing T Cell Therapy for Patients with Lymphoma
17/06/2025 -
Ashvattha Therapeutics to Present Data on Novel Nanomedicine Radiotracers at SNMMI Annual Meeting
17/06/2025 -
Scienture Holdings Announces Cancelation of ELOC
17/06/2025 -
IMUNON Announces PlaCCine® DNA Vaccine Technology Abstract Selected for Oral Presentation at 10th International Conference on Vaccines Research & Development™
17/06/2025 -
CHO Plus Selected for 2025 BioTools Innovator Accelerator Program
17/06/2025 -
FOXO TECHNOLOGIES INC.’S CRITICAL ACCESS HOSPITAL ANNOUNCES NEW WOUND CARE SERVICES OFFERING
17/06/2025 -
Microbot Medical Strengthens Global IP Portfolio with Newly Granted Patent in China
17/06/2025 -
X-Chem Strengthens Executive Team with Strategic Finance and HR Appointments
17/06/2025 -
Lipella Pharmaceuticals Announces U.S. Patent Issuance for Diagnostic Technology
17/06/2025 -
Cannabix Technologies Receives Notice of Allowance from USPTO for Contactless Breath Analysis
17/06/2025 -
AIM ImmunoTech Resumes Trading on NYSE American
17/06/2025 -
Ernst & Young LLP (EY US) Announces Jason Matuszewski, CEO of BioStem Technologies, as an Entrepreneur Of The Year® 2025 Florida Award Winner
17/06/2025 -
Femasys Names New Chief Commercial Officer to Drive Execution and Global Growth
17/06/2025 -
Lark Health Names Industry Veteran Matthew Gibbs as President and Launches LarkVantage, an A.I. GLP-1 Cost Containment Platform
17/06/2025
Pages